ClinicalTrialsFinder

Refractory Mantle Cell Lymphoma Clinical Trials in Rochester, Minnesota

1 recruitingRochester, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 2

Tafasitamab, Lenalidomide and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell LymphomaRefractory Mantle Cell Lymphoma
Academic and Community Cancer Research United100 enrolled2 locationsNCT05910801